Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp75 | Bone development/growth and fracture repair | ECTS2014

Low calcium-phosphate diet attenuates dietary protein deficiency-mediated impairment of bone growth by blunting the decrease in serum IGF1 and in hepatic GH receptor gene expression

Fournier Carole , Rizzoli Rene , Ammann Patrick

Low protein diet (LPD) impairs body growth, decreases serum IGF1 and increases serum FGF21, two hepatokines influencing bone growth. Low calcium-phosphate diet (LCaPiD) increases serum calcitriol. We hypothesized that LPD effects on bone growth may differ according to calcium and phosphate intakes through the hormonal modulation of calcitriol, IGF1 and FGF21. One-month old rats were fed isocaloric diets containing 10 or 5% casein (10Prot, 5Prot), with 1.0% calcium and 0.8% pho...

ba0003pp97 | Cancer and bone: basic, translational and clinical | ECTS2014

TRAF2, but not TRAF6, regulates breast cancer induced osteoclastogenesis and osteolysis.

Peramuhendige Prabha , Marino Silvia , Mollat Patrick , Idris Aymen I.

Tumour necrosis factor receptor associated factors (TRAFs) play a key role in signal transduction in mammalian cells. Several members of the TRAF family have been identified but only TRAF2 and TRAF6 are implicated in the regulation of osteoclastogenesis. Here we studied the role of TRAF2 and TRAF6 in breast cancer induced bone cell activity and osteolysis. We observed that TRAF2, but not TRAF6, is highly expressed in the human MDA-MB-231 (MDA-231) bone-seeking breast cancer ce...

ba0005p220 | Chondrocytes and cartilage | ECTS2016

Role of matrilin-3 in the development of osteoarthritis

Seifer Patrick , Heilig Juliane , Niehoff Anja , Paulsson Mats , Zaucke Frank

Introduction: The matrilin-3 polymorphism T298M has been described to be associated with hand osteoarthritis in the carpometacarpal joint 1 (CMC1) and with spinal disc degeneration. In vitro studies revealed that expression levels, processing and secretion of matrilin-3 T298M were similar to the wt protein. Structural analysis indicated an impact on the formation of collagen II/IX/XI heterofibrils, whereas the binding to collagen was not affected. We have now generate...

ba0001pp311 | Osteoporosis: evaluation and imaging | ECTS2013

Appropriate osteoporosis treatment by family physicians in response to FRAX vs caroc reporting: a randomized controlled trial

Beattie Karen , Ioannidis George , MacDermid Joy , Grewal Ruby , Papaioannou Alexandra , Hodsman Anthony , Adachi Jonathan D

Introduction: Current Canadian clinical practice guidelines recommend the FRAX or Canadian Association of Radiologists and Osteoporosis Canada (CAROC) fracture risk assessment tools to report 10-year fracture risk in an individual. CAROC considers sex, age, BMD and previous fracture as risk factors. It is unknown whether one reporting system is more effective in helping general practitioners (GPs) identify individuals who should be recommended for pharmacological treatment. We...

ba0003pp313 | Osteoporosis: treatment | ECTS2014

Preclinical evaluation of the link module from human TSG--6 as a novel anti-resorptive agent for postmenopausal osteoporosis

Kanakis Ioannis , Scott Jenny , Thomson Jennifer , Hassall Giles , Hardman Matthew , Milner Caroline , Day Anthony

We have shown previously that TSG–6 acts as an autocrine regulator of osteoclast activity in vitro, capable of inhibiting RANKL-mediated osteoclastic bone resorption with a similar potency to OPG1,2. Thus, the TSG–6 protein has the potential to be developed as a novel treatment for osteoporosis, which is associated with excessive bone loss3.The aim of this study was to determine the therapeutic potential of the is...

ba0001pp55 | Bone biomechanics and quality | ECTS2013

In vivo microindentation for the assessment of bone material level properties

Ammann Patrick , Guerri Roberto , Hansma Paul , Nogues Xavier , Diez-Perez Adolfo

A micro-indentation technology potentially allows in vivo investigation of intrinsic bone tissue quality, a determinant of bone fragility. Thus the signification of the parameters investigated is still unclear.Since protein malnutrition affects bone material level properties – geometry and strength – rats were fed a normal or an isocaloric low-protein diet. Both femurs were collected and measurements of geometry using micro CT, materia...

ba0001pp185 | Cell biology: osteoblasts and bone formation | ECTS2013

DNA-damage, survival, differentiation, and matrix mineralization in vitro of a murine multipotent mesenchymal precursor cell line

Lau Patrick , Hu Yueyuan , Hellweg Christine E , Baumstark-Khan Christa , Reitz Gunther

Radiation therapy is one of the most effective and indispensable treatment modalities for cancer patients. Known tissue complications caused by radiation-induced stem cell depletion, may result in structural and functional alterations of the surrounding matrix. Although, studies have demonstrated that ionizing radiation can induce apoptosis and senescence, little is known about the effects of therapeutic irradiation concerning the commitment of mesenchymal stem cells to the os...

ba0001pp186 | Cell biology: osteoblasts and bone formation | ECTS2013

Involvement of Runx2 in the differentiation process of osteoblastic precursor cells after radiation exposure

Hu Yueyuan , Lau Patrick , Hellweg Christine , Baumstark-Khan Christa , Reitz Guenther

Astronauts on exploratory space missions will experience a complex environment that includes microgravity and radiation. While the deleterious effects of unloading on bone are well established, fewer studies have focused on the effects of radiation. Space radiation produces distinct biological damages which, up to now, little is known about the correlation between radiation exposure and bone tissue. In our study we used osteoblastic precursor cells to investigate the radiation...

ba0001pp457 | Other diseases of bone and mineral metabolism | ECTS2013

DPP4 inhibition attenuates bone loss in diabetic rats

Glorie Lorenzo , Behets Geert , Baerts Lesley , De Meester Ingrid , D'Haese Patrick , Verhulst Anja

Dipeptidyl peptidase 4 (DPP4) modulates activity of proteins by removing two aminoterminal amino acids. DPP4 inhibitors are currently being used to improve glucose tolerance in type 2 diabetes patients by increasing the half-life of DPP4 substrates. It has been shown that these substrates do not only increase pancreatic insulin secretion, but also influence bone cell activity. The potential therapeutic effect of DPP4 inhibition on bone metabolism is thus worth being investigat...